Cargando…

Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis

OBJECTIVE: Depression is reported to be relatively common in idiopathic pulmonary fibrosis (IPF) patients. Thus far, however, whether or not depression independently determines the health-related quality of life (HRQOL) has not been evaluated exclusively in IPF patients. We designed this study to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Toshiaki, Taniguchi, Hiroyuki, Ando, Masahiko, Kondoh, Yasuhiro, Kimura, Tomoki, Kataoka, Kensuke, Nishimura, Koichi, Nishiyama, Osamu, Sakamoto, Koji, Hasegawa, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519463/ https://www.ncbi.nlm.nih.gov/pubmed/28674350 http://dx.doi.org/10.2169/internalmedicine.56.7019

Ejemplares similares

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study
por: Fukihara, Jun, et al.
Publicado: (2017)

Significance of Pulmonary Arterial Pressure as a Prognostic Indicator in Lung-Dominant Connective Tissue Disease
por: Suzuki, Atsushi, et al.
Publicado: (2014)

The St. George’s Respiratory Questionnaire as a prognostic factor in IPF
por: Furukawa, Taiki, et al.
Publicado: (2017)

Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
por: Suzuki, Atsushi, et al.
Publicado: (2018)

Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study
por: Takahashi, Kota, et al.
Publicado: (2016)

Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis
por: Nishiyama, Osamu, et al.
Publicado: (2021)

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022)

The COPD assessment test and St George’s Respiratory Questionnaire: are they equivalent in subjects with COPD?
por: Morishita-Katsu, Mariko, et al.
Publicado: (2016)

Acute respiratory distress syndrome due to severe pulmonary tuberculosis treated with extracorporeal membrane oxygenation: A case report and review of the literature
por: Omote, Norihito, et al.
Publicado: (2016)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023)

The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial
por: Suzuki, Atsushi, et al.
Publicado: (2020)

Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
por: Nakano, Akiko, et al.
Publicado: (2020)

Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer: A retrospective observational study
por: Oi, Hajime, et al.
Publicado: (2022)

Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021)

Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation
por: Oi, Hajime, et al.
Publicado: (2020)

Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Suzuki, Atsushi, et al.
Publicado: (2016)

Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
por: Bando, Tomohiro, et al.
Publicado: (2022)

Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis
por: Nemoto, Masahiro, et al.
Publicado: (2021)

Respiratory failure patient with lung cancer diagnosed by transesophageal bronchoscopic ultrasound‐guided aspirates
por: Ito, Takayasu, et al.
Publicado: (2018)

Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy
por: Kataoka, Kensuke, et al.
Publicado: (2023)

A Volumetric Computed Tomography Analysis of the Normal Lung in Idiopathic Pulmonary Fibrosis: The Relationship with the Survival
por: Ohkubo, Hirotsugu, et al.
Publicado: (2017)

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
por: Taniguchi, Hiroyuki, et al.
Publicado: (2011)

A Pilot Study of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in the Diagnosis of Peripheral Pulmonary Lesions in Patients with Interstitial Lung Disease
por: Ito, Takayasu, et al.
Publicado: (2021)

Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias
por: Ozasa, Mutsumi, et al.
Publicado: (2018)

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2017)

Pneumothorax in patients with idiopathic pulmonary fibrosis: a real-world experience
por: Yamazaki, Ryo, et al.
Publicado: (2021)

Endobronchial Ultrasonography with a Guide Sheath Transbronchial Biopsy for Diagnosing Peripheral Pulmonary Lesions within or near Fibrotic Lesions in Patients with Interstitial Lung Disease
por: Ito, Takayasu, et al.
Publicado: (2021)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
por: Akiyama, Norimichi, et al.
Publicado: (2022)

Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment
por: Azuma, Arata, et al.
Publicado: (2011)

Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020)

Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing
por: Yamauchi, Hiroyoshi, et al.
Publicado: (2016)

Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy
por: Kondoh, Yasuhiro, et al.
Publicado: (2018)

Comparison of CURB-65, PSI, and qSOFA for predicting pneumonia mortality in patients with idiopathic pulmonary fibrosis
por: Yamazaki, Ryo, et al.
Publicado: (2021)

Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
por: Kondoh, Yasuhiro, et al.
Publicado: (2022)

Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Ebina, Masahito, et al.
Publicado: (2011)

Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis
por: Yamamoto, Yuji, et al.
Publicado: (2020)

Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19
por: Omote, Norihito, et al.
Publicado: (2021)

Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system
por: Mutoh, Yoshikazu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jk8ms3a5nlllk9vmutbc8a1umi